相关实验视频

Updated: Jan 16, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

在长期持久性心房的老年患者中,穿过导管心房 Septal 缺陷关闭的影响

Yuki Matsubara¹, Michiyo Yamano¹, Tetsuhiro Yamano¹

¹Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.

International heart journal

|October 1, 2025

概括

过导管心房隔膜缺陷 (ASD) 关闭有效地治疗心脏衰竭在老年患者心房动 (AF). 该程序改善了心脏功能和症状,即使在那些长期持久的AF.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
心脏成像 - - 心脏成像

背景情况:

对于老年患者,已建立过导管心房隔膜缺陷 (ASD) 关闭.
在ASD关闭后,长期持续性心房动 (AF) 的老年患者的结局需要进一步调查.
在这个特定的队列中,心脏重塑和症状进展尚未完全理解.

研究的目的:

为了比较心脏改造和通过导管ASD关闭后的症状改善,在老年患者中与AF (AF-ASD) 相比,这些患者的鼻节律 (SR-ASD).
阐明ASD关闭对AF老年患者心脏结构和功能的长期影响.

主要方法:

对52名经过过导管ASD关闭的患者 (>70岁) 的回顾性分析.
从基线到手术后1年,评估了连续心声图,NYHA功能分类和血BNP水平.
与AF患者和SR患者之间的比较.

主要成果:

在两组中,右侧腔室发生了显著的反向改造,长达1年.
与SR-ASD组相比,AF-ASD组的左心房体积明显增加.
在这两组中,NYHA功能类改善,在AF-ASD组中,血BNP水平显著下降.

结论:

过导管ASD关闭在老年患有ASD和长期持久性AF的患者心力衰竭中有效.
该程序在这个人群中促进了有利的心脏重塑和症状改善.
左心房重塑在AF和SR患者关闭后不同.

关键词:

成年人的先天性心脏病.进行心脏重塑.心脏衰竭是因为心脏衰竭.干预干预干预

更多相关视频

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...